| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 04/28/1999 | CN1215335A Method fo treating heart failure with endothelin antagonists |
| 04/28/1999 | CN1043140C Hydroxymethyl furazane carboxylic acid derivatives and its preparation process and medicinal composition |
| 04/28/1999 | CA2248270A1 Novel dbpb |
| 04/27/1999 | CA2163778C Indole derivatives as steroid 5a-reductase inhibitors |
| 04/27/1999 | CA2122246C Phospholipid antimicrobial compositions |
| 04/24/1999 | CA2248170A1 A clone hwhhj20 |
| 04/22/1999 | WO1999019479A1 Murine model for human carcinoma |
| 04/22/1999 | WO1999019346A1 Dipeptides for the treatment of diseases related to the biological effect of endothelin |
| 04/22/1999 | WO1999019320A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors |
| 04/22/1999 | WO1999019300A1 Prostaglandin agonists and their use to treat bone disorders |
| 04/22/1999 | WO1999019299A1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof |
| 04/22/1999 | WO1999019293A1 Novel aryloxy-alkyl-dialkylamines |
| 04/22/1999 | WO1999018961A1 Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus |
| 04/22/1999 | WO1999018952A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
| 04/22/1999 | WO1999018801A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 04/22/1999 | WO1999018781A1 Dipeptide apoptosis inhibitors and the use thereof |
| 04/22/1999 | WO1999001136A9 Novel substituted imidazole compounds |
| 04/22/1999 | CA2307929A1 Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors |
| 04/22/1999 | CA2306062A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 04/22/1999 | CA2305643A1 Murine model for human carcinoma |
| 04/22/1999 | CA2305499A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors |
| 04/22/1999 | CA2305353A1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof |
| 04/22/1999 | CA2304374A1 Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus |
| 04/21/1999 | EP0909564A1 Erythropoietin solution preparation |
| 04/21/1999 | EP0909175A1 Non-aqueous protic peptide formulations |
| 04/21/1999 | EP0909174A1 TREATMENT OF CYSTIC DISEASE WITH TNF-$g(a) |
| 04/21/1999 | EP0885217A4 Endothelin receptor antagonists |
| 04/21/1999 | EP0882039A4 Endothelin receptor antagonists |
| 04/21/1999 | EP0633261B1 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 04/21/1999 | CN1214682A Eprosartan dihydrate and process for its production and formulation |
| 04/21/1999 | CN1214339A Pyrazole derivatives, their preparation and their use in pharmaceuticals |
| 04/20/1999 | US5895783 Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor |
| 04/15/1999 | WO1999018120A1 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/15/1999 | WO1999017797A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | WO1999017777A1 Inhibitors of prenyl-protein transferase |
| 04/15/1999 | WO1999017772A1 5ht4 agonists and antagonists |
| 04/15/1999 | WO1999008668A3 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 04/15/1999 | WO1999008666A3 Pharmaceutical composition comprising an azateroid |
| 04/15/1999 | WO1999005170A8 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 04/15/1999 | WO1999004773A3 Method for inhibiting bone resorption |
| 04/15/1999 | DE19745151A1 New N-2-Mercapto-3-phenyl-propionyl di:peptide derivatives |
| 04/15/1999 | DE19745146A1 New N-acyl N-acyl-aminoethyl alpha-amino acid derivatives |
| 04/15/1999 | CA2306746A1 Inhibitors of prenyl-protein transferase |
| 04/15/1999 | CA2306452A1 Use of growth differentiation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | CA2304826A1 5ht4 agonists and antagonists |
| 04/14/1999 | EP0908519A1 Novel glucosaminidase from Staphylococcus aureus |
| 04/14/1999 | EP0908459A1 5-HT4 Agonists and antagonists |
| 04/14/1999 | EP0908456A1 Pyrazole derivatives, their preparation and their use in drugs |
| 04/14/1999 | EP0907735A1 Modulators of tissue regeneration |
| 04/14/1999 | EP0907658A1 Neuropeptide y agonists |
| 04/14/1999 | EP0907318A1 Antioxidant compound |
| 04/14/1999 | EP0748221B1 7-substituted-4-aza-steroid derivatives as 5-alpha- reductase inhibitors |
| 04/14/1999 | CN1042933C Benzoylguanidine, prepn. of same and application as pharmaceutical and pharmaceutical containing same |
| 04/09/1999 | CA2246635A1 Novel glucosaminidase |
| 04/08/1999 | WO1999016881A1 Antigen protein and nucleic acid coding for said protein |
| 04/08/1999 | WO1999016741A2 Lipophilic diesters of chelating agents |
| 04/08/1999 | WO1999016452A1 THERAPEUTICALLY EFFECTIVE 1α, 25-DIHYDROXYVITAMIN D3 ANALOGS |
| 04/08/1999 | WO1999016444A1 Endothelin antagonist and beta receptor blocking agent as combined preparations |
| 04/08/1999 | WO1999016437A1 Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients |
| 04/08/1999 | WO1998056913A9 Smad6 and uses thereof |
| 04/08/1999 | CA2304056A1 Therapeutically effective 1.alpha., 25-dihydroxyvitamin d3 analogs |
| 04/07/1999 | EP0906959A2 Aminopeptidase from Staphylococcus aureus |
| 04/07/1999 | EP0906282A1 Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators |
| 04/07/1999 | EP0906276A1 Novel vitamin d analogues |
| 04/07/1999 | EP0906108A1 Method of treating heart failure with endothelin antagonists |
| 04/07/1999 | EP0906100A1 Use of 5-ht 1a? receptor antagonists for the treatment of urinary incontinence |
| 04/07/1999 | EP0781268B1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system |
| 04/07/1999 | EP0647266B1 D-enzyme compositions and methods of their use |
| 04/07/1999 | EP0632033B1 Novel benzopyran derivative |
| 04/07/1999 | CN1213307A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213303A Method of increasing sphincter competence |
| 04/06/1999 | US5892039 Piperazino derivatives as neurokinin antagonists |
| 04/06/1999 | US5891672 Polynucleotides encoding GTP cyclohydrolase II (ribA) |
| 04/06/1999 | US5891670 Tetracycline resistance protein |
| 04/06/1999 | US5891341 Compositions and devices for partitioning advanced glycosylation endproducts, and methods of their use |
| 04/01/1999 | WO1999015657A2 53bp2 complexes |
| 04/01/1999 | WO1999015500A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/1999 | WO1999015498A1 New npy antagonists |
| 04/01/1999 | WO1999015494A1 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 04/01/1999 | WO1999015490A1 C3a receptor ligands |
| 04/01/1999 | WO1999015160A2 Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 04/01/1999 | DE19743143A1 Pharmazeutische Kombinationspräparate Pharmaceutical combination preparations |
| 04/01/1999 | CA2303943A1 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 04/01/1999 | CA2303918A1 Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 04/01/1999 | CA2303883A1 C3a receptor ligands |
| 04/01/1999 | CA2303528A1 New npy antagonists |
| 04/01/1999 | CA2303405A1 53bp2 complexes |
| 04/01/1999 | CA2302572A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/1999 | CA2246004A1 A kringle-related clone, hthbz47 |
| 03/31/1999 | EP0905250A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA |
| 03/31/1999 | EP0905248A1 Staphylococcus aureus MurE protein and nucleic acids encoding it |
| 03/31/1999 | EP0905245A1 Staphylococcal polypeptides Spo0J1 |
| 03/31/1999 | EP0905243A2 Polynucleotides from Staphylococcus aureus expressed in infected tissue |
| 03/31/1999 | EP0905142A1 Inhibitors against prostate-specific antigen |
| 03/31/1999 | EP0904260A1 Inhibition of matrix metalloproteases by 2-(omega-aroylalkyl)-4-biaryl-oxobutyric acids |
| 03/31/1999 | EP0904110A1 Nitric oxide donors capable of reducing toxicity from drugs |
| 03/31/1999 | EP0904080A1 Inhibitors of farnesyl-protein transferase |
| 03/31/1999 | EP0904076A1 Inhibitors of farnesyl-protein transferase |
| 03/31/1999 | EP0904073A1 Zwitterionic compositions and methods as biological response modifiers |
| 03/31/1999 | EP0660711B1 Novel use of inhibitors of phosphodiestersase iv |